Abstract

TRPV6, a Ca-selective channel, is abundantly expressed in the placenta, intestine, kidney and bone marrow. TRPV6 is vital to Ca homeostasis and its defective expression or function is linked to transient neonatal hyperparathyroidism, Lowe syndrome/Dent disease, renal stone, osteoporosis and cancers. The fact that the molecular mechanism underlying the function and regulation of TRPV6 is still not well understood hampers, in particular, the understanding of how TRPV6 contributes to breast cancer development. By electrophysiology and Ca imaging in Xenopus oocytes and cancer cells, molecular biology and numerical simulation, here we reveal an intramolecular S5/S6 helix interaction in TRPV6 that is functionally autoinhibitory and is mediated by the R532:D620 bonding. Predicted pathogenic mutation R532Q within S5 disrupts the S5/S6 interaction leading to gain-of-function of the channel, which promotes breast cancer cell progression through strengthening of the TRPV6/PI3K interaction, activation of a PI3K/Akt/GSK-3β cascade, and up-regulation of epithelial-mesenchymal transition and anti-apoptosis.

Highlights

  • transient receptor potential (TRP) vanilloid 6 (TRPV6), a Ca-selective channel, is abundantly expressed in the placenta, intestine, kidney and bone marrow

  • By use of the two-electrode voltage clamp electrophysiology in Xenopus oocytes as an expression model we found that, compared with wildtype (WT) TRPV6, the TRPV6 R532Q mutant is of substantial GOF, with a 50-fold increase in the currents induced by 5 mM extracellular Ca (Fig. 1a) but unaffected surface membrane expression (Figs. 1b and S1), indicating the functional importance of R532

  • Ca imaging, molecular biology and molecular dynamics (MD) simulation, our present study identified an autoinhibitory intramolecular S5/S6 helix interaction and showed that this interaction is mediated by the R532:D620 pair of residues located in proximal S5 and distal S6, respectively

Read more

Summary

Introduction

TRPV6, a Ca-selective channel, is abundantly expressed in the placenta, intestine, kidney and bone marrow. TRPV6 is vital to Ca homeostasis and its defective expression or function is linked to transient neonatal hyperparathyroidism, Lowe syndrome/Dent disease, renal stone, osteoporosis and cancers. The fact that the molecular mechanism underlying the function and regulation of TRPV6 is still not well understood hampers, in particular, the understanding of how TRPV6 contributes to breast cancer development. By electrophysiology and Ca imaging in Xenopus oocytes and cancer cells, molecular biology and numerical simulation, here we reveal an intramolecular S5/S6 helix interaction in TRPV6 that is functionally autoinhibitory and is mediated by the R532:D620 bonding. Abnormal expression or function of TRPV6 is linked to male fertility, transient neonatal hyperparathyroidism, kidney stone formation, and carcinoma[2] but the underlying mechanisms have remained largely unclear. Similar to other TRP channels, TRPV6 has cytosolic N- and C-termini and six membrane-spanning domains, with aspartic acid residue 582

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call